Logos Global Corporation – Trademark Portfolio
Entity Type: 03
Logos Global Corporation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EBIEN. The owner is based in McAllen, TX.
P.O. Box 6542
McAllen, TX 78502
Showing of trademarks Trademarks
Trademark Classifications
Logos Global Corporation's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Logos Global Corporation have?
Logos Global Corporation has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Logos Global Corporation file in?
Logos Global Corporation files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Logos Global Corporation's most well-known trademarks?
Logos Global Corporation's registered trademark portfolio includes well-known marks such as EBIEN. These are among 1 currently registered trademark in the portfolio.
What is Logos Global Corporation's trademark registration success rate?
Logos Global Corporation has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.